These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28324844)

  • 21. Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy.
    Kulikov AV; Gainetdinov RR; Ponimaskin E; Kalueff AV; Naumenko VS; Popova NK
    Expert Opin Ther Targets; 2018 Apr; 22(4):319-330. PubMed ID: 29542343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP; Santos AR; Rodrigues AL
    Brain Res Bull; 2005 Sep; 67(1-2):53-61. PubMed ID: 16140163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
    Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
    J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice.
    Kim JW; Ahn HS; Baik JH; Yoon BJ
    J Psychopharmacol; 2013 Feb; 27(2):171-80. PubMed ID: 22992375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.
    Wang S; Chen Y; Liu X; Xu X; Liu X; Liu BF; Zhang G
    Arch Pharm (Weinheim); 2014 Jan; 347(1):32-41. PubMed ID: 24214603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.
    Guiard BP; Lanfumey L; Gardier AM
    Curr Drug Targets; 2006 Feb; 7(2):187-201. PubMed ID: 16475960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
    Lucki I; O'Leary OF
    J Clin Psychiatry; 2004; 65 Suppl 4():11-24. PubMed ID: 15046537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles.
    Bowman MA; Gomez JA; Mitchell NC; Wells AM; Vitela M; Clarke KM; Horton RE; Koek W; Daws LC
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.
    Gabrielsen M; Wołosewicz K; Zawadzka A; Kossakowski J; Nowak G; Wolak M; Stachowicz K; Siwek A; Ravna AW; Kufareva I; Kozerski L; Bednarek E; Sitkowski J; Bocian W; Abagyan R; Bojarski AJ; Sylte I; Chilmonczyk Z
    Chem Biol Drug Des; 2013 Jun; 81(6):695-706. PubMed ID: 23574807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT
    Yoshinaga H; Masumoto S; Koyama K; Kinomura N; Matsumoto Y; Kato T; Baba S; Matsumoto K; Horisawa T; Oki H; Yabuuchi K; Kodo T
    Bioorg Med Chem; 2017 Jan; 25(1):293-304. PubMed ID: 27865645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
    Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
    Romero L; Hervás I; Artigas F
    Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
    Lucas G; Rymar VV; Du J; Mnie-Filali O; Bisgaard C; Manta S; Lambas-Senas L; Wiborg O; Haddjeri N; Piñeyro G; Sadikot AF; Debonnel G
    Neuron; 2007 Sep; 55(5):712-25. PubMed ID: 17785179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.
    Dawson LA; Watson JM
    CNS Neurosci Ther; 2009; 15(2):107-17. PubMed ID: 19499624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
    Gardier A
    Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter.
    Butler SG; Meegan MJ
    Curr Med Chem; 2008; 15(17):1737-61. PubMed ID: 18673223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.